Literature DB >> 6976375

Delayed hypersensitivity granuloma formation around Schistosoma mansoni eggs in vitro. I. Definition of the model.

B L Doughty, S M Phillips.   

Abstract

An in vitro model of granuloma formation was established in order to study the cellular interactions involved in the formation of delayed hypersensitivity granulomas and the cellular interactions responsible for host modulation of that response in chronic infections of schistosomiasis. This model utilizes Schistosoma mansoni eggs from adult worm pairs that have been cultured in vitro as an antigenic source and spleen cells from either normal or actively infected C57BL/6 mice as the cell donors. The results establish a consistent sequence of events characterized by initial adherence of mononuclear cells to the egg; subsequent blast transformation by these cells; recruitment of additional mononuclear cell populations, including lymphocytes and macrophages; and recruitment of eosinophils and fibroblasts, which are capable of synthesizing collagen. The immunologic nature of this reaction has been established through analyses after presensitization either by natural infection or through the use of soluble egg antigen. These studies have demonstrated the immunologic specificity of the reaction, its dependence on an initial T lymphocyte-mediated event, and recruitment of other cell populations. Preliminary studies show that modulation in vitro reflects the in vivo kinetics of granuloma modulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976375

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Allogeneic substitution for nominal antigen-specific T-cell clone reactivity in schistosomiasis.

Authors:  G P Linette; P J Lammie; S M Phillips
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

2.  Adult Schistosoma mansoni worms positively modulate soluble egg antigen-induced inflammatory hepatic granuloma formation in vivo. Stereological analysis and immunophenotyping of extracellular matrix proteins, adhesion molecules, and chemokines.

Authors:  W Jacobs; J Bogers; A Deelder; M Wéry; E Van Marck
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Evolution of the schistosomal hepatic lesions in mice after curative chemotherapy.

Authors:  Z A Andrade; J A Grimaud
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

Review 4.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation.

Authors:  Y Shikama; K Kobayashi; K Kasahara; S Kaga; M Hashimoto; I Yoneya; S Hosoda; K Soejima; H Ide; T Takahashi
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

6.  T-lymphocyte responsiveness in murine schistosomiasis mansoni is dependent upon the adhesion molecules intercellular adhesion molecule-1, lymphocyte function-associated antigen-1, and very late antigen-4.

Authors:  J G Langley; D L Boros
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Splenic and granuloma T-lymphocyte responses to fractionated soluble egg antigens of Schistosoma mansoni-infected mice.

Authors:  N W Lukacs; D L Boros
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Antibody-dependent cellular cytotoxicity of Coxiella burnetii-infected J774 macrophage target cells.

Authors:  F T Koster; T L Kirkpatrick; J D Rowatt; O G Baca
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro.

Authors:  T Gaafar; S Ismail; M Helmy; A Afifi; N Guirguis; R el Ridi
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man.

Authors:  N Ohta; Y K Nishimura; M Iuchi; T Sasazuki
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.